RT Book, Section
A1 Johnston, Peter V.
A1 Gerstenblith, Gary
A2 Yuh, David D.
A2 Vricella, Luca A.
A2 Yang, Stephen C.
A2 Doty, John R.
SR Print(0)
ID 1104593900
T1 Stem Cells for Cardiac Surgical Disease
T2 Johns Hopkins Textbook of Cardiothoracic Surgery
YR 2014
FD 2014
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-166350-2
LK accesssurgery.mhmedical.com/content.aspx?aid=1104593900
RD 2024/10/03
AB There  are  an  estimated  5.8  million  people  in  the  United  States  with  heart  failure.1Stem  cell  therapy  for  the  heart  represents  a  novel  method  by  which  dysfunctional  cardiac  tissue  might  be  repaired  or  replaced,  thereby  alleviating  heart  failure  and  decreasing  or  eliminating  life-threatening  arrhythmias.Potential  sources  of  stem  cell  therapy  for  the  heart  include  the  bone  marrow,  circulating  progenitor  cells,  embryonic  stem  cells,  and  the  heart  itself.Multiple  modalities  exist  for  delivery  of  stem  cell  therapy  to  the  heart,  including  traditional  and  minimally  invasive  surgical  methods  as  well  as  intravenous  and  percutaneous  catheter-based  techniques.